Humanigen Inc.: Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective. It focuses on preventing the serious and potentially life-threatening side-effects associated with chimeric antigen receptor T-cell (CAR-T) therapy. Its pipeline includes programs such as Lenzilumab, Ifabotuzumab, and HGen005.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - Pacific
Listing
Public, USA
Market Cap
500MM - 1B
Address:
533 Airport Blvd
Suite 400
Burlingame, CA 94010
United States

Top 10 Holders of Humanigen Inc

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Valiant Capital Management LP 26.75 6,034,483 78.18 Stakes 7/29/20
Black Horse Capital Management LLC 12.35 2,785,258 36.08 Stakes 9/18/20
First Light Asset Management LLC 3.57 804,598 10.42 13F 6/30/20
Polar Capital LLP 2.22 500,000 6.48 Funds 8/28/20
BlackRock Advisors LLC 1.78 402,353 5.21 Funds 9/30/20
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.